Nemaura Medical Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nemaura Medical Inc. - overview
Established
2011
Location
Loughborough, -, UK
Primary Industry
Medical Devices & Equipment
About
Nemaura Medical Inc. specializes in developing innovative solutions in the healthcare sector, focusing on non-invasive glucose monitoring to enhance diabetes management and improve patient care. Founded in 2011 in Loughborough, UK, Nemaura Medical Inc. is dedicated to creating advanced healthcare products.
The company has consistently focused on enhancing its market strategy. Nemaura Medical is known for its flagship product, which offers a non-invasive glucose monitoring system designed to aid diabetes management. The company was founded by a team with substantial experience in medical technology. Nemaura Medical Inc.
provides a suite of innovative healthcare solutions, primarily focusing on their non-invasive glucose monitoring device, which was launched in 2020. This platform allows patients to track glucose levels without the need for finger pricking, offering a comfortable and user-friendly experience. The product is particularly targeted towards individuals with diabetes, enabling better management of their condition. The company’s offerings have expanded to include advanced features such as real-time monitoring and integrated health data analytics, aiming to cater to a global clientele, particularly in North America and Europe.
Nemaura Medical Inc. operates on a subscription-based revenue model, providing clients access to their glucose monitoring service through various pricing tiers. These plans are designed to accommodate different user needs, allowing for both monthly and annual subscription options. This structure ensures flexibility as users' health monitoring requirements evolve.
By establishing strategic partnerships, Nemaura enhances its service offerings and builds long-term client relationships, benefiting from recurring revenue streams associated with its innovative products. Nemaura Medical Inc. is actively developing additional features and enhancements for its glucose monitoring system, with plans to launch these updates by the end of 2021. The company aims to expand its market presence into Asia and South America by 2022, focusing on regions with a high prevalence of diabetes.
Proceeds from the most recent funding round on April 21, 2020, will be utilized to support these advancements and facilitate entry into new markets.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment
Website
www.nemauramedical.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Nemaura Medical Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Debt | Completed | Nemaura Medical Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.